Literature DB >> 23168565

Thrombin induces release of proinflammatory chemokines interleukin-8 and interferon-γ-induced protein-10 from cultured human fetal astrocytes.

Sarah Simmons1, Richard V Lee, Thomas Möller, Jonathan R Weinstein.   

Abstract

Thrombin is a multifunctional serine proteinase that induces a variety of responses from neural cells by cleavage of proteinase-activated receptors (PARs) including PAR1 and PAR4. Thrombin/PAR signaling has been implicated in the neuroinflammatory response that occurs in the brain following stroke and other central nervous system pathologies. The neuroinflammatory response involves astrocytes and results in induction of proinflammatory chemokines including interleukin-8 (IL-8 or CXCL8) and interferon-γ-induced protein-10 (IP-10 or CXCL10) in these cells. Astroctyes are known to express PARs, however the effect of thrombin on astrocytic chemokine secretion is unknown. Here we characterize the ability of thrombin to induce proliferation/metabolic activity and chemokine secretion in primary human fetal astrocytes. Thrombin induces dose-dependent astrocyte proliferation as well as release of both IL-8 and IP-10, but not IL-6 or the chemokine regulated and normal T cell expressed and secreted (RANTES). The chemokine responses were mimicked by PAR1, but not PAR4, activating peptides. Our data indicate that astrocytic chemokine release is part of the neuroinflammatory response triggered by the exposure of the central nervous system to thrombin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23168565      PMCID: PMC9013510          DOI: 10.1097/WNR.0b013e32835c1de4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

1.  Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia.

Authors:  L L Hua; S C Lee
Journal:  Glia       Date:  2000-03       Impact factor: 7.452

2.  Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.

Authors:  Hong Wang; Joachim J Ubl; Georg Reiser
Journal:  Glia       Date:  2002-01       Impact factor: 7.452

3.  The microglia-activating potential of thrombin: the protease is not involved in the induction of proinflammatory cytokines and chemokines.

Authors:  Uwe-Karsten Hanisch; Denise van Rossum; Yiheng Xie; Klaus Gast; Rolf Misselwitz; Seppo Auriola; Gundars Goldsteins; Jari Koistinaho; Helmut Kettenmann; Thomas Möller
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

Review 4.  Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Authors:  S R Coughlin
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

5.  Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors.

Authors:  Jonathan R Weinstein; Sarah Swarts; Caroline Bishop; Uwe-Karsten Hanisch; Thomas Möller
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

Review 6.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 7.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 8.  Chemokines in ischemia and reperfusion.

Authors:  Nikolaos G Frangogiannis
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

9.  Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.

Authors:  Candice E Junge; C Justin Lee; Katherine B Hubbard; Zhoabin Zhang; Jeffrey J Olson; John R Hepler; Daniel J Brat; Stephen F Traynelis
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

Review 10.  Role of glial cells in cerebral ischemia.

Authors:  Maiken Nedergaard; Ulrich Dirnagl
Journal:  Glia       Date:  2005-06       Impact factor: 8.073

View more
  7 in total

Review 1.  Role of the protease-activated receptor 1 in regulating the function of glial cells within central and peripheral nervous system.

Authors:  Elena Pompili; Cinzia Fabrizi; Francesco Fornai; Lorenzo Fumagalli
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

2.  A New Strategy for Deleting Animal drugs from Traditional Chinese Medicines based on Modified Yimusake Formula.

Authors:  Jinghui Wang; Yan Li; Yinfeng Yang; Xuetong Chen; Jian Du; Qiusheng Zheng; Zongsuo Liang; Yonghua Wang
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

3.  Early anticoagulation therapy for severe burns complicated by inhalation injury in a rabbit model.

Authors:  Zhong-Hua Fu; Guang-Hua Guo; Zhen-Fang Xiong; Xincheng Liao; Ming-Zhuo Liu; Jinhua Luo
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

4.  CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage.

Authors:  Margaret J Landreneau; Michael T Mullen; Steven R Messé; Brett Cucchiara; Kevin N Sheth; Louise D McCullough; Scott E Kasner; Lauren H Sansing
Journal:  Ann Clin Transl Neurol       Date:  2018-07-03       Impact factor: 4.511

5.  Salmon and human thrombin differentially regulate radicular pain, glial-induced inflammation and spinal neuronal excitability through protease-activated receptor-1.

Authors:  Jenell R Smith; Peter P Syre; Shaina A Oake; Kristen J Nicholson; Christine L Weisshaar; Katrina Cruz; Robert Bucki; Bethany C Baumann; Paul A Janmey; Beth A Winkelstein
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

6.  Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury.

Authors:  Luping Huang; Lin Zhang; Huiming Ju; Qingtian Li; Jenny Szu-Chin Pan; Zahraa Al-Lawati; David Sheikh-Hamad
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

7.  Integrated analysis of ischemic stroke datasets revealed sex and age difference in anti-stroke targets.

Authors:  Wen-Xing Li; Shao-Xing Dai; Qian Wang; Yi-Cheng Guo; Yi Hong; Jun-Juan Zheng; Jia-Qian Liu; Dahai Liu; Gong-Hua Li; Jing-Fei Huang
Journal:  PeerJ       Date:  2016-09-15       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.